We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current ABMC market cap is 4.81k. The company's latest EPS is USD -0.0293 and P/E is 0.00.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.87M | 3.66M | 4.15M | 2.22M | 913k |
| Operating Income | -762k | -593k | -621k | -1.18M | -1.33M |
| Net Income | -1.03M | -681k | -796k | -463k | -1.41M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.48M | 2.08M | 1.93M | 1.88M | 1.27M |
| Total Liabilities | 2.62M | 2.87M | 3.18M | 2.83M | 3.61M |
| Total Equity | -146k | -790k | -1.26M | -944k | -2.34M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -220k | 58k | -483k | -673k | -768k |
| Investing | -22k | N/A | -4k | N/A | N/A |
| Financing | 319k | -167k | 581k | 690k | 687k |
| Market Cap | 4.81k |
| Price to Earnings Ratio | 0.00 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 48.1M |
| Average Volume (1 week) | 1.33k |
| Average Volume (1 Month) | 1.33k |
| 52 Week Change | -98.89% |
| 52 Week High | 0.0168 |
| 52 Week Low | 0.000001 |
| Spread (Intraday) | 0 (0%) |
| Company Name | American Bio Medica Corporation (CE) |
| Address |
122 smith road kinderhook, new york 12106 |
| Website | https://www.abmc.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
